<p>A: LV end-systolic diameters 24 hour post -MI. The LV end-systolic diameter increased in diabetic mice compared with non-diabetic values (*<i>p</i><0 05 vs. non diabetic # <i>p</i><0.05 vs. diabetes values are presented as means ± SD). B: Fractional shortening (FS): CoPP treatment increased FS compared to the untreated diabetic ones SnPP abolished the beneficial effect (*<i>p</i><0.05 vs. non diabetic # <i>p</i><0.01 vs. diabetes, <sup>$</sup><i>p</i><0.05 vs. diabetes + CoPP values are presented as means ± SD; n = 7 in control and CoPP group; n = 5 in other groups values are presented as means ± SD).</p
<p>(<b>A</b>) Glucose tolerance test (GTT) (<b>B</b>) GTT A.U.C. in LFD, HFDM and HFDL treated mice....
<p><b>A-B</b>: The representative mice from the control (A) and PGDM groups (B). <b>C</b>: The bar c...
Diabetes, obesity and dyslipidemia are associated with a significant increase in cardiovascular morb...
<p>Data are expressed as mean±SEM. RV, Right Ventricle; LV, Left Ventricle.</p><p>refers to effect o...
AIMS: Type II diabetes, often associated with abdominal obesity, frequently leads to heart failure. ...
It is unclear whether the increase in availability of sub-strates for energy production in diabetes ...
Background: Diabetes mellitus (DM) is associated with an increased risk of cardiovascular disease (C...
<p>Echocardiographic analysis was performed at 10 weeks of age. Values are means ± SEM; n, number of...
<p>Cardiac structural remodeling in non-diabetic (Cn) and diabetic (DM) mice treated with vehicle or...
<p>Larger decrease in %FS (B) and ï (C) in diabetic mice compared to control mice. Decrease in diast...
<p>Fractional shortening (FS) (A), Vcfc (B), LV systolic pressure (LVSP) (C), peak positive dP/dt (D...
The incidence of diabetes and its association with increased cardiovascular disease risk represents ...
BACKGROUND: Type 2 diabetes is frequently associated with co-morbidities, including hypertension. He...
<p>Data are expressed relative to non-diabetic vehicle-treated mice as mean±SEM. Abbreviations are e...
<div><p>Background</p><p>Type 2 diabetes is frequently associated with co-morbidities, including hyp...
<p>(<b>A</b>) Glucose tolerance test (GTT) (<b>B</b>) GTT A.U.C. in LFD, HFDM and HFDL treated mice....
<p><b>A-B</b>: The representative mice from the control (A) and PGDM groups (B). <b>C</b>: The bar c...
Diabetes, obesity and dyslipidemia are associated with a significant increase in cardiovascular morb...
<p>Data are expressed as mean±SEM. RV, Right Ventricle; LV, Left Ventricle.</p><p>refers to effect o...
AIMS: Type II diabetes, often associated with abdominal obesity, frequently leads to heart failure. ...
It is unclear whether the increase in availability of sub-strates for energy production in diabetes ...
Background: Diabetes mellitus (DM) is associated with an increased risk of cardiovascular disease (C...
<p>Echocardiographic analysis was performed at 10 weeks of age. Values are means ± SEM; n, number of...
<p>Cardiac structural remodeling in non-diabetic (Cn) and diabetic (DM) mice treated with vehicle or...
<p>Larger decrease in %FS (B) and ï (C) in diabetic mice compared to control mice. Decrease in diast...
<p>Fractional shortening (FS) (A), Vcfc (B), LV systolic pressure (LVSP) (C), peak positive dP/dt (D...
The incidence of diabetes and its association with increased cardiovascular disease risk represents ...
BACKGROUND: Type 2 diabetes is frequently associated with co-morbidities, including hypertension. He...
<p>Data are expressed relative to non-diabetic vehicle-treated mice as mean±SEM. Abbreviations are e...
<div><p>Background</p><p>Type 2 diabetes is frequently associated with co-morbidities, including hyp...
<p>(<b>A</b>) Glucose tolerance test (GTT) (<b>B</b>) GTT A.U.C. in LFD, HFDM and HFDL treated mice....
<p><b>A-B</b>: The representative mice from the control (A) and PGDM groups (B). <b>C</b>: The bar c...
Diabetes, obesity and dyslipidemia are associated with a significant increase in cardiovascular morb...